Investor Relations Home - Achieve Life Sciences

Investors Home

Home 2017-06-16T21:39:52+00:00

Investors Home

Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisinicline as a smoking cessation aid to address the global tobacco and nicotine addiction epidemic.

Stock Info

Recent Press Releases

Recent News
Feb 24, 2021

SEATTLE, Wash. and VANCOUVER, British Columbia, February 24, 2021 - Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

Feb 11, 2021

SEATTLE, Wash and VANCOUVER, British Columbia / ACCESSWIRE / February 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global...

Jan 7, 2021

SEATTLE, Wash. and VANCOUVER, British Columbia, January 7, 2021 - - Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...